Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting - Yahoo Finance

However, it is estimated that up to 30% of patients with mild or moderate ulcerative colitis require add-on therapy to aminosalicylate (5-ASA) drugs. Patients refractive to treatment with 5-ASA drugs typically receive a course of an oral ...

Phase 3 Study of Simponi for Ulcerative Colitis - Monthly Prescribing Reference

All trial patients had failed to respond to or tolerate treatment with 6-mercaptopurine (6-MP), azathioprine (AZA), corticosteroids and/or 5-aminosalicylate (5-ASA), or were corticosteroid dependent. Study participants were naive to treatment with tumor ...

Are My Patients Taking Their Meds? - Medscape News

This is not difficult with IBD medications. No 5-ASA product needs to be taken more than twice a day, and most can be taken once a day whether the patient has active disease or is in remission. Thiopurines can also be taken once a day. Most trials used a ...

Prescott fleshes out summer tourney schedule - Daily Courier

Pioneer Park Aug. 1-5 - ASA Girls' 18-and-Under Class A Fast-Pitch Western National; multiple fields Aug. 11-12 - Chuck, Keith and Jones Co-Ed Slow-Pitch Tourney; Pioneer Park Aug. 18-19 - ASA Women's Senior Slow-Pitch Softball Tourney; Pioneer Park ...

Breaking from the pack - Marshall Independent

REDWOOD FALLS - Morning rains made it a bit difficult to maneuver around some muddy areas on grounds of the Redwood Valley High School track and field facility for Thursday's 3A Sub-Section 11 meet, but once the athletes got their feet on the track, runway ...

Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript) - Seekingalpha.com

Our PDUFA date is in the middle of October. We have also initiated a follow-on trial and add-on therapy to the 5-ASA, and I’ll just say more about that in just a moment. The IBD opportunity is significant, this is a pie chart of the landscape of branded ...

New Phase 3 Study Results Show Anti-TNF SIMPONI Induced Clinical Response in Adults With Moderately to Severely Active Ulcerative Colitis - Phramalive.com

All trial patients had failed to respond to or tolerate treatment with 6-mercaptopurine (6-MP), azathioprine (AZA), corticosteroids and/or 5-aminosalicylate (5-ASA), or were corticosteroid dependent. Study participants were naive to treatment with TNF ...